UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 400

Sortiert nach

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

Diabetologia, 2009-12, Vol.52 (12), p.2499-2506

2009

Volltextzugriff (PDF)

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials

Diabetologia, 2010-09, Vol.53 (9), p.1838-1845

2010

Volltextzugriff (PDF)

randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

Diabetologia, 2008-03, Vol.51 (3), p.408-416

2008

Volltextzugriff (PDF)

The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences

Diabetes, obesity & metabolism, 2012-09, Vol.14 (9), p.780-788

Home, P. D.

2012

Volltextzugriff (PDF)

Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK

Diabetic medicine, 2013-06, Vol.30 (6), p.681-686

2013

Volltextzugriff (PDF)

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?

Diabetes, obesity & metabolism, 2015-11, Vol.17 (11), p.1011-1020

Home, P. D.

2015

Volltextzugriff (PDF)

Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria

Diabetologia, 2009-08, Vol.52 (8), p.1464-1473

2009

Volltextzugriff (PDF)

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial

Diabetic medicine, 2000-11, Vol.17 (11), p.762-770

2000

Volltextzugriff (PDF)

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) : study design and protocol

Diabetologia, 2005-09, Vol.48 (9), p.1726-1735

2005

Volltextzugriff (PDF)

Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart

Diabetic medicine, 2006-08, Vol.23 (8), p.879-886

2006

Volltextzugriff (PDF)

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

Diabetic medicine, 2002-05, Vol.19 (5), p.393-399

2002

Volltextzugriff (PDF)

Rosiglitazone RECORD study: glucose control outcomes at 18 months

Diabetic medicine, 2007-06, Vol.24 (6), p.626-634

2007

Volltextzugriff (PDF)

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes

Diabetic medicine, 2006-03, Vol.23 (3), p.285-292

2006

Volltextzugriff (PDF)

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study

International journal of clinical practice (Esher), 2010-11, Vol.64 (12), p.1609-1618

2010

Volltextzugriff (PDF)

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

Diabetes, obesity & metabolism, 2015-04, Vol.17 (4), p.386-394

2015

Volltextzugriff (PDF)

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

Diabetic medicine, 2012-06, Vol.29 (6), p.716-720

2012

Volltextzugriff (PDF)

Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes

Diabetic medicine, 2010-01, Vol.27 (1), p.37-45

2010

Volltextzugriff (PDF)

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times

Diabetic medicine, 2006-01, Vol.23 (1), p.46-52

2006

Volltextzugriff (PDF)

Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.179-187

2015

Volltextzugriff (PDF)

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

Diabetic medicine, 2009-10, Vol.26 (10), p.1027-1032

2009

Volltextzugriff (PDF)

A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

Diabetes/metabolism research and reviews, 2005-11, Vol.21 (6), p.545-553

2005

Volltextzugriff (PDF)

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers

European journal of clinical pharmacology, 1999-05, Vol.55 (3), p.199-203

1999

Volltextzugriff (PDF)

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

Diabetes, obesity & metabolism, 2015-09, Vol.17 (9), p.835-842

2015

Volltextzugriff (PDF)

A common fallacy of observational medication studies in diabetes

Diabetes, obesity & metabolism, 2015-04, Vol.17 (4), p.317-318

Home, P. D.

2015

Volltextzugriff (PDF)

Biosimilar insulins: guidance for data interpretation by clinicians and users

Diabetes, obesity & metabolism, 2015-10, Vol.17 (10), p.911-918

2015

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(345)
Mit Volltextzugriff
(295)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(279)
Life Sciences & Biomedicine
(228)
Humans
(220)
Endocrinology & Metabolism
(147)
Male
(144)
Biological And Medical Sciences
(141)
Medical Sciences
(124)
Female
(123)
Adult
(101)
Middle Aged
(94)
Endocrinopathies
(64)
Endocrine Pancreas. Apud Cells
(59)
Aged
(58)
Diabetes. Impaired Glucose Tolerance
(58)
Diabetes
(52)
Insulin - Administration & Dosage
(52)
Blood Glucose - Metabolism
(48)
Blood Glucose - Analysis
(46)
Diabetes Mellitus, Type 1 - Drug Therapy
(45)
Hypoglycemic Agents - Therapeutic Use
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials

randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences

Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?

Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD) : study design and protocol

Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

Rosiglitazone RECORD study: glucose control outcomes at 18 months

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with Type 1 diabetes

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes

Friedewald equation underestimates low-density lipoprotein cholesterol at low concentrations in young people with and without Type 1 diabetes

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times

Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

A common fallacy of observational medication studies in diabetes

Biosimilar insulins: guidance for data interpretation by clinicians and users

Suchergebnisse filtern